Cita APA

Bontempi, I., Díaz, G. F., Leal ,Karen, Prochetto, E. S., Borsuk, S., Dellagostin, O., & Marcipar, I. S. (2020). Recombinant mycobacterium bovis bcg is a promising platform to develop vaccines against Trypansoma Cruzi infections. Web

Citación estilo Chicago

Bontempi, Iván, Genaro Francisco Díaz, Leal ,Karen, Estefanía Soledad Prochetto, Sibele Borsuk, Odir Dellagostin, and Iván Sergio Marcipar. Recombinant Mycobacterium Bovis Bcg Is a Promising Platform to Develop Vaccines against Trypansoma Cruzi Infections. 2020.

Cita MLA

Bontempi, Iván, et al. Recombinant Mycobacterium Bovis Bcg Is a Promising Platform to Develop Vaccines against Trypansoma Cruzi Infections. 2020.